|Year : 2020 | Volume
| Issue : 2 | Page : 156-162
Comparative assessment of periodontal regeneration in periodontal intraosseous defects treated with PepGen P-15 unaided or in blend with platelet-rich fibrin: A clinical and high-resolution computed tomography scan-assisted volumetric analysis
Jyotsna Goyal1, Surinder Sachdeva2, Sanjeev Kumar Salaria3, Nishu Vakil4, Amit Mittal5
1 Department of Periodontology, Luxmi Bai Institute of Dental Sciences and Hospital, Patiala, Punjab, India
2 Department of Periodontology, Maharishi Markandeshwar College of Dental Sciences and Research, Maharishi Markandeshwar University, Mullana, Haryana, India
3 Department of Periodontology and Implantology, Surendera Dental College and Research Institute, Sri Ganganagar, Rajasthan, India
4 Department of Periodontology, Indira Gandhi Government Dental College, Jammu, Jammu and Kashmir, India
5 Department of Radiodiagnosis, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar University, Mullana, Haryana, India
|Date of Submission||25-Jun-2019|
|Date of Decision||22-Dec-2019|
|Date of Acceptance||29-Dec-2019|
|Date of Web Publication||02-Mar-2020|
Dr. Jyotsna Goyal
Department of Periodontology, Luxmi Bai Institute of Dental Sciences and Hospital, 8 Km Milestone, Sirhind Road, Patiala - 147 001, Punjab
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: PepGen P-15, a xenograft, has proven its periodontal regenerative potential. Platelet-rich fibrin (PRF) is an autologous platelet concentrate which too contributes to periodontal redevelopment through the release of different polypeptide progression factors. The present study intended to evaluate the regenerative potential of PepGen P-15 xenograft when used unaccompanied or in blend with PRF in periodontal intraosseous defects in humans through clinical and a novel computed tomography (CT) scan analysis technique. Materials and Methods: Twelve chronic periodontitis individuals with paired periodontal intraosseous defects were randomly treated either with PepGen P-15 exclusively (Control/Group A) or in concoction with PRF (Test/Group B) utilizing split-mouth study design. Pocket probing depth (PPD), relative attachment level (RAL), and relative position of gingival margin were assessed at 3- and 6-month interval, whereas the linear and volumetric bone defect regeneration were assessed at 6 months postoperatively using CT scan. Results: Both the groups validated statistically significant PPD reduction, RAL gain at 3 and 6 months, but on intergroup comparison, test group CT images revealed significantly greater linear bone gain and volumetric bone gain, with mean difference of 0.73 ± 0.28 (P = 0.018) and 2.70 ± 1.36 (P = 0.06) at 6 months in comparison to the baseline data. Conclusions: PepGen P-15 and PRF blend had better regeneration potential for the management of intrabony defects. Further long-term investigations on large sample size are recommended to authenticate the same.
Keywords: Computed tomography scan, intrabony defects, PepGen P-15, periodontal regeneration, platelet-rich fibrin
|How to cite this article:|
Goyal J, Sachdeva S, Salaria SK, Vakil N, Mittal A. Comparative assessment of periodontal regeneration in periodontal intraosseous defects treated with PepGen P-15 unaided or in blend with platelet-rich fibrin: A clinical and high-resolution computed tomography scan-assisted volumetric analysis. J Indian Soc Periodontol 2020;24:156-62
|How to cite this URL:|
Goyal J, Sachdeva S, Salaria SK, Vakil N, Mittal A. Comparative assessment of periodontal regeneration in periodontal intraosseous defects treated with PepGen P-15 unaided or in blend with platelet-rich fibrin: A clinical and high-resolution computed tomography scan-assisted volumetric analysis. J Indian Soc Periodontol [serial online] 2020 [cited 2022 Jul 5];24:156-62. Available from: https://www.jisponline.com/text.asp?2020/24/2/156/279612
| Introduction|| |
Harmonized refurbishment of all the supporting, investing, and surrounding structure of periodontium with coronal migration of junctional epithelium attachment on the cured periodontal disease cemental root surface remains a challenge for the periodontist. In spite of different periodontal regenerative attempts till date, we have not been able to regenerate the optimum inherent periodontal apparatus lost in the course of disease progression.
Among different regenerative materials only patients own bone grafts, demineralized freeze-dried bone allograft (DFDBA) and an organic bovine-derived matrix with P-15 (ABM/P-15 or PepGen P-15) have shown to have periodontal regenerative efficacy histologically. PepGen P-15 is a tissue-engineered bone graft that consists of both inorganic and organic components. An organic bovine-derived matrix resembles natural bone in term of its anatomical skeleton, structural, and composition which is essential for cellular incursion, whereas organic component consists of type I collagen and a 15 amino acid sequence which provides a cordial habitat for osteoblasts and fibroblasts, etc. However, studies regarding PepGen P-15 are scarce in the literature. Furthermore, platelet concentrates such as platelet-rich fibrin (PRF) act as an autogenous fibrin network with leukocytes to propagate the osteoblasts by exciting the production of osteoprotegerin to promote periodontal regeneration by liberating growth factors, and show neo-angiogenic properties. Ample evidences are reported in the literature in the favor of PRF associated periodontal regeneration when used unaided or in amalgamation with grafts in different periodontal hard-tissue defects,,, and soft-tissue defects (marginal gingival tissue recession), etc. Hence, it was hypothesized that PRF as an adjunct to PepGen P-15 might yield a better result than PepGen P-15 alone which has not been analyzed/published yet to the best of our information.
Although histologic picture and surgical reentry has been considered a reliable tool to assess the periodontal regeneration in treated cases, mostly, it is not possible because of ethical concerns and nonacceptability of the patients. To overcome all these deficiencies, the present split-mouth study was designed for the estimation the regeneration potential of PepGen P-15 (¶) unaided or in blend with PRF in periodontal intraosseous defects clinically and radiographically, utilizing high-resolution computed tomography [Philips Ingenuity MDCT, Netherland (#)] scan-assisted volumetric analysis.
| Materials and Methods|| |
Fifteen patients of chronic periodontitis with bilateral deep intrabony defects were enrolled out of 417 patients who were referred to the institutional outpatient department of periodontology, based on the inclusion criterion. All the enrolled patients underwent Phase I periodontal therapy, but only 12 (10 males, 2 females; of age range between 25 and 55 years with a mean age of 40 years) patients submitted written signed consent and they were treated as per the revised Helsinki Declaration (2008). The selected patients were randomly allocated utilizing sequential numbered, opaque, and sealed envelopes to each treatment group just before the surgery by a noninvestigating examiner.
Chronic periodontitis patients with normal platelet count concentration, age between 25-60 years of either gender, having minimal two intra osseous defect in each/contra lateral arch with probing depth (PPD)≥ 5mm as well as osseous defect well observed on IOPA x-ray taken using parallel profile radiography technique, orthopantomogram, and then confirmed by using ingenuity; 128 Slice MDCT, Philips Medical Systems, Netherland software at baseline were the inclusion criterion for the study as shown in [Figure 1]a [Figure 1]b [Figure 1]c and [Figure 2]a [Figure 2]b [Figure 2]c for CT scan evaluation of defect; [Figure 3]a and [Figure 4]a for pre-operative PD and [Figure 3]d and [Figure 4]d for osseous defect observed on IOPA X-ray).
|Figure 1: (a,d) Preoperative and postoperative Dentascan Images of control group at baseline and 6 month post operatively; (b) the three dimensional (3D) osseous defect assessment at baseline; (e) 3D model of reconstructed osseous defect size 6 month post operatively; (c) linear bone defect measurements at baseline; (f) linear defect volume remain after reconstruction at 6 month post operatively|
Click here to view
|Figure 2: (a and d) Preoperative and postoperative dentascan images of test group; (b and d) three dimensional model of linear bone defect before and after reconstruction; (c and e) volumetric bone defect before and after reconstruction surgery|
Click here to view
|Figure 3: Intraoperative view, Group A: (a) Preoperative periodontal probing 6 mm from marginal gingiva to base of pocket; (b) Open osseous defect measurement; (c) Postoperative probing at 6 months postoperatively; (d) Preoperative intra oral peri apical (IOPA) X-ray showing intraosseous defect; (e) 6 months postoperative osseous defect regeneration|
Click here to view
|Figure 4: Intraoperative view, Group B: (a) Preoperative periodontal probing 6 mm from marginal gingiva to base of pocket; (b) Open osseous defect measurement; (c) Postoperative probing at 6 months postoperatively; (d) Preoperative intra oral peri apical (IOPA) X-ray showing intraosseous defect; (e) 6 months postoperative osseous defect regeneration|
Click here to view
Adverse habits such as smoking and alcohol consumption, any potential medical complications and any disorder affecting the treatment plan and wound healing, pregnant and nursing women, any known reaction to any of the materials proposed to be utilized in the study, mobility of teeth, furcation defects, and flawed endodontic/conservative treatment were excluded from the study.
All the selected patients had gone thorough oral prophylaxis as well as subgingival root planing followed by oral hygiene instructions. Oral hygiene maintenance therapy and motivation carried out at weekly interval, and the patients responded well with good oral hygiene within 6–8 weeks after the initial therapy.
Preoperative clinical parameters assessed
Plaque index (PI) and gingival index (GI) were evaluated with respect to a localized tooth having intraosseous defects, in addition to full-mouth PI, GI and gingival sulcus bleeding index (SBI) were recorded at the baseline (zero time). Occlusal stents were fabricated and grooves were placed to standardize the position of the periodontal probe **(CP 15 UNC, Hu-Friedy Chicago, IL, USA) and to accurately compare the pre- and postoperative measurements including PPD, relative position of the gingival margin (REC), and relative attachment level (RAL). RAL and REC were measured using the most apical end of the stent as a reference, while PPD was measured from the gingival margin.
Osseous defect morphology was determined using 3D CT with the following technical parameters: slice thickness of 0.67 mm, exposure of 120 kV, and 150 mA with a 0° gantry orientation. Following image acquisition in three sections consisting of axial, sagittal, and coronal planes, as measured with the help of digital calipers, the images were reconstructed using the software provided with the CT system. The area of interest was extracted, and threshold processing was performed allow clear visualization of the defect [Figure 1]c and [Figure 2]c pre operatively and [Figure 1]f and [Figure 2]f post operatively]. All linear and volumetric measurements were calculated to the nearest to 0.1mm. All linear and volumetric measurements were calculated to the nearest to 0.1 mm. The analyzed hard-tissue parameters included depth of bony defect (cementoenamel junction [CEJ] to the base of the defect [BOD] minus CEJ to alveolar crest [AC]), AC level, defect volume, and linear bone defect height (CEJ to the BOD at the baseline A0) and were recorded by another trained blind investigator who was not the part of study, whereas surgeries were performed by a single-trained clinician.
Platelet-rich fibrin preparation
It was carried out just immediately before the surgical intervention from patients own 10 ml blood sample collected in pre sterile test tube and centrifuged at 2700 rpm, for 10 min as per the Choukroun's protocol, in a centrifuge unit (REMI, India).
Surgical procedures/intrasurgical measurements
Under a septic surgical protocol, surgical sites were anesthetized using 2% local anesthesia with adrenaline. Full-thickness periodontal flaps were reflected followed by thorough root planing and the defect was debrided. The open defect measurements from the BOD to the apical end of the stent (BD-AS) as shown [Figure 3]b and [Figure 4]b and from AC-AS were measured utilizing UNC-15 probe. The defect depth was calculated as the difference between the two, that is, AS to BD minus AS to AC.
PepGen P-15 graft alone or in blend with PRF clot fragments were packed till the crest of bone defects in Group A and B, respectively. The patients were instructed regarding the postoperative oral hygiene measures.
PI, GI, SBI, PPD, RAL were recorded at 3 and 6 month interval [Figure 3]c and 4c showed PPD 6 month interval]. IOPA X ray was also taken at 6 month post operatively to observe the bone changes too [Figure 3]e and [Figure 4]e whereas linear bone growth (LBG), volumetric bone gain (VBG) [Figure 1]d, [Figure 1]e, [Figure 1]f and [Figure 2]d, [Figure 2]e, [Figure 2]f and LBG % and VBG% change were recorded by CT scan for both the groups 6 months post operatively groups.
Linear bone growth = Linear bone defect height at 6 months A1–Linear bone defect height at baseline A0
Linear bone growth%change = A1-A0/A0 X 100
All the data obtained from the different parameters assessed at respected time intervals of the study protocol were analyzed utilizing IBM SPSS Statistics for Windows, version 21.0 (IBM Corp., Armonk, NY., USA). The Wilcoxon signed -rank test was performed for intragroup comparison value); independent 't' test for intergroup comparison of clinical parameters (t) where paired 't' and independent 't' was performed for LBG as well as VBG intra and intergroup comparison. P < 0.05/>0.05 was considered statistical significant/nonsignificant, respectively.
| Results|| |
All the 12 patients selected for the surgical procedure had completed the study without any complication. Out of full mouth PI, GI, and SBI scores as well as PI and GI at teeth with the intraosseous defect, only PI and GI scores only on intragroup comparison showed statistically significant changes (P < 0.002) [Table 1].
|Table 1: Mean and mean differences in plaque index, gingival index, and sulcular bleeding index of Group A, Group B, and Group A versus Group B at different intervals|
Click here to view
The reduction in PPD, RAL, and REC on intragroup comparison in Group A and B at 3 and 6 months postoperatively found to be statistically significant (P = 0.002), respectively, but only significant improvement (P < 0.008) was observed in RAL at 6-month interval on intergroup comparison [Table 2].
|Table 2: Mean and mean differences in probing pocket depth, relative attachment level, and relative position of gingival margin of Group A, Group B, and Group A versus Group B at different intervals|
Click here to view
Both Group A and Group B reported significant intragroup improvements (P < 0.001) in terms of mean amount and % of changes in linear bone gain (LBG) and VBG, but more, pronounced changes observed in mean difference 2.17 ± 0.72 (LBD), 7.02 ± 4.23 (VBG) and 30.33 ± 8.36 (%LBG) as well as 58.08 ± 18.14 (%VBG) in group B. LBG, VBG, % of LBG and VBG were also reported to be statistically significant (P = 0.018, 0.06, 0.17 and 0.08) respectively on intergroup comparison too [Table 3] and [Table 4].
|Table 3: Mean, mean differences, and percentage of linear bone growth (DENTASCAN) of Group A, Group B, and Group A versus B at different intervals|
Click here to view
|Table 4: Mean, mean differences and percentage of volumetric bone gain (DENTASCAN) of Group A, Group B and Group A versus B at different intervals|
Click here to view
| Discussion|| |
Conventional intraoral radiographs provided only the buccal and lingual view of intrabony defects, whereas CT scan has advantages over conventional radiographs because of its skill for 3D analysis of bone defect image with high precision and resolution,, as well as it is a noninvasive way to assess the bone regeneration in the periodontal bone defects reported by Naito et al., Ito et al., and Pradeep et al., etc. Therefore, advance high-resolution CT was selected in the present study.
PepGen P-15 xenograft has been considered in the present study due to its favorable clinical and histologic profile, and enhanced attachment of cells in vitro since it is an anorganic bovine-derived hydroxyapatite (HA) bone matrix representing a regular HA skeleton and appears to behave more physiologically during wound healing. It has been shown that the P-15 helps in the binding of cells particularly fibroblasts and osteoblasts. Different researchers have been reported clinical efficiency and superiority of ABM/P-15 to other bone graft materials, and open-flap debridement.
The PRF coagulate boosts cellular migration through its fibrin framework, accelerated wound healing, neovascularization, and cicatricial tissue remodeling. PRF secure and take care of the implanted material by acting as a genetic connector between implanted graft particles. During resorption phase, PRF steadily released cytokines, thereby generating a long-lasting process of healing. Finally, the presence of different leucocytes and cytokines within the fibrin web plays an extensive role in the self-regulation of inflammatory and infectious phenomena within the imbedded material. Greater improvement reported in the periodontal soft-tissue parameter (PPD, CAL, etc.) and radiographic bone gain with the use of unaided PRF in comparison to conventional flap surgery in three-wall periodontal bone defects,, Grade II furcal defect, PRF in blend with bone grafts in the treatment of three-wall osseous defects, and comparable regenerative potential of PRF to DFDBA in periodontal intraosseous defects, in marginal tissue recession coverage.
Periodontal regeneration of three-wall intraosseous defect by the use of ABM/P-15 unaided and in blend with PRF was not published yet to the best of our information achieved through the web of literature search. Thus, it has been reserved in thoughts that no direct comparative assessment is available. The study results showed that the mean PPD reduction was marginally greater in the Group B than Group A, which is in consistency with the report of Lekovic et al., but they have utilized PRF with bovine porous bone mineral (BPBM) or PRF alone in the handling intrabony periodontal defects. Intragroup comparison at different time intervals in both the groups showed significant changes, which is in consistency with the report of Pradeep et al. but they have utilized autologous platelet-rich plasma (PRP) and peptide-enhanced bone graft (PEBG); Fatima et al. used Pepgen P-15 as a graft material alone in the handling of periodontal osseous defects in vivo. A significant improvement in the relative position of the marginal gingiva (REC) in coronal direction was observed in group B from 0 to 6 months interval but was reported to be nonsignificant on intergroup comparison which is contrary to the report of Pradeep et al.
Comparatively, greater gain in RAL was observed in Group B in comparison to Group A from 0- to 6-month interval, respectively, with a significant intergroup difference which is consistence with the reports of Pradeep et al., but they have observed the gain in clinical attachment level with PRP and PEBG and fusion of PRF with HA bone graft for the management of three-wall intrabony defects in the patients suffering from chronic periodontitis; the report of Piemontese et al. treated intraosseous defects with DFDBA in blend with PRP. DFDBA in blend with PRP; and partially in consistency to the report of Fatima et al. as they observed significant difference only on intragroup comparison only. The gain in RAL in each group of our study may be attributed to the periodontal regeneration associated with ABM/P-15 which is in consistence with the report of Yukna et al., which further enhanced when blend of ABM/P-15 and PRF was utilized. The gain in RAL (clinical attachment gain) in both the groups is in consistence with the reports of Pradeep et al., but have compared different implanted materials; Mishra et al. evaluated open-flap therapy with or without ABM/P-15; Juneja and Bharti utilized PRF and HA in the intrabony defects in vivo. Greater and significant mean LBG and VBG were observed in the ABM/P-15+ PRF group after 6 months, as compared to ABM/P-15 group which was in consistence with the report Pradeep et al., but they evaluated the defect fill and original defect resolution till 9 months postoperatively utilizing spiral 3D CT scan. The significant intergroup comparison may be attributed due to multiple reasons (i) synchronized effect of PepGen P-15 and PRF, as preceder surfaces imitate the role of native collagen matrix in wound healing; and its deposition is an important component of repair in tissue. It also promotes matrix mineralization by exciting the osteoblastic activity by improving the BMP-2, BMP-7, alkaline phosphatase, and osteogenic factors expression, which might help in regenerating the periodontal tissues; (ii) PRF due to their distinguishing properties,,, enhances the regenerative effect when used in combination with bone graft, which might be because two diverse healing processes may take place collectively which may probably result in their synergistic effect; and (iii) increased sensitivity, specificity determination, and quantification through CT scan as compared to conventional radiographs.
| Conclusions|| |
PepGen P-15 bone graft in conjunction with flap surgery was an effective periodontal regenerative potential in terms of linear bone growth and VBG for the management of three-wall bone defects. However, the outcome achieved further enhanced when the same treatment protocol is used in blend with PRF.
¶PepGen P-15® (250–420 μ) (DENTSPLY Friadent CeraMed, Lakewood, CO, USA).
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Susin C, Wikesjö UM. Regenerative periodontal therapy: 30 years of lessons learned and unlearned. Periodontol 2000 2013;62:232-42.
Zander HA, Polson AM, Heijl LC. Goals of periodontal therapy. J Periodontol 1976;47:261-6.
Hegedus Z. The rebuilding of the alveolar process by bone transplantation. Dent Cosmos 1923;65:736-42.
Chang IC, Tsai CH, Chang YC. Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A 2010;95:327-32.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al
. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e45-50.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al
. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e51-5.
Samuel MA, Abou Khadr MA, Koura AS, Madi MI. The effect of platelet rich fibrin on angiogenesis during periodontal regeneration. Alexandria Dental Journal 2017;42:182-6.
Sharma A, Pradeep AR. Autologous platelet-rich fibrin in the treatment of mandibular degree II furcation defects: A randomized clinical trial. J Periodontol 2011;82:1396-403.
Salaria SK, Ghuman SK, Kumar S, Sharma G. Management of localized advance loss of periodontal support associated Grade II furcation and intrabony defect in chronic periodontitis patient through amalgamation of platelet-rich fibrin and hydroxyapatite bioactive glass composite granules. Contemp Clin Dent 2016;7:405-8.
] [Full text]
Salaria SK, Chahal NK, Chahal SS, Singh P. Single flap approach with lingual access in conjugation with PRF and Biograft HABG for the management of residual grade II furcation defect occurring from primary endodontic with secondary periodontal lesion: An interdisciplinary case report. J Pharma Biomed Sci 2016;6:18-22.
Taneja N, Kudwa P, Goswami M, Bhat GK, Kudwa HP. A comparative evaluation of platelet rich fibrin with metronidazole and platelet rich fibrin alone in the treatment of intrabony defect. J Interdiscip Dent 2017;7:101-10.
Salaria SK, Kaur S, Sharma I, Ramalingam K. Coronally advance flap in conjunction with platelet rich fibrin assisted immediate management of residual soft tissue defect following surgical excision of recurrent pyogenic granuloma in the maxillary esthetic segment. J Indian Soc Periodontol 2018;22:273-6.
] [Full text]
Grimard BA, Hoidal MJ, Mills MP, Mellonig JT, Nummikoski PV, Mealey BL. Comparison of clinical, periapical radiograph, and cone-beam volume tomography measurement techniques for assessing bone level changes following regenerative periodontal therapy. J Periodontol 2009;80:48-55.
Misch KA, Yi ES, Sarment DP. Accuracy of cone beam computed tomography for periodontal defect measurements. J Periodontol 2006;77:1261-6.
Walter C, Schmidt JC, Dula K, Sculean A. Cone beam computed tomography (CBCT) for diagnosis and treatment planning in periodontology: A systematic review. Quintessence Int 2016;47:25-37.
Naito T, Hosokawa R, Yokota M. Three-dimensional alveolar bone morphology analysis using computed tomography. J Periodontol 1998;69:584-9.
Ito K, Yoshinuma N, Goke E, Arai Y, Shinoda K. Clinical application of a new compact computed tomography system for evaluating the outcome of regenerative therapy: A case report. J Periodontol 2001;72:696-702.
Pradeep AR, Shetty SK, Garg G, Pai S. Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects. J Periodontol 2009;80:62-71.
Yukna R, Salinas TJ, Carr RF. Periodontal regeneration following use of ABM/P-1 5: A case report. Int J Periodontics Restorative Dent 2002;22:146-55.
Kleinman HK, Klebe RJ, Martin GR. Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 1981;88:473-85.
Lallier TE, Yukna R, St Marie S, Moses R. The putative collagen binding peptide hastens periodontal ligament cell attachment to bone replacement graft materials. J Periodontol 2001;72:990-7.
Yukna RA, Callan DP, Krauser JT, Evans GH, Aichelmann-Reidy ME, Moore K, et al
. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results. J Periodontol 1998;69:655-63.
Barros RR, Novaes AB Jr., Roriz VM, Oliveira RR, Grisi MF, Souza SL, et al
. Anorganic bovine matrix/p-15 “flow” in the treatment of periodontal defects: Case series with 12 months of follow-up. J Periodontol 2006;77:1280-7.
Bhongade ML, Tiwari IR. A comparative evaluation of the effectiveness of an anorganic bone matrix/cell binding peptide with an open flap debridement in human infrabony defects: A clinical and radiographic study. J Contemp Dent Pract 2007;8:25-34.
Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: Implant surgery, prosthodontics, and survival. Implant Dent 2009;18:220-9.
Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the treatment of intra-bony defects: A controlled clinical trial. J Clin Periodontol 2011;38:925-32.
Lekovic V, Milinkovic I, Aleksic Z, Jankovic S, Stankovic P, Kenney EB, et al
. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects. J Periodontal Res 2012;47:409-17.
Chadwick JK, Mills MP, Mealey BL. Clinical and radiographic evaluation of demineralized freeze-dried bone allograft versus platelet-rich fibrin for the treatment of periodontal intrabony defects in humans. J Periodontol 2016;87:1253-60.
Rehan M, Khatri M, Bansal M, Puri K, Kumar A. Comparative evaluation of coronally advanced flap using amniotic membrane and platelet-rich fibrin membrane in gingival recession: An 18-month clinical study. Contemp Clin Dent 2018;9:188-94.
] [Full text]
Fatima G, Shivamurthy R, Thakur S, Baseer MA. Evaluation of anorganic bovine-derived hydroxyapatite matrix/cell binding peptide as a bone graft material in the treatment of human periodontal infrabony defects: A clinico-radiographic study. J Indian Soc Periodontol 2015;19:651-8.
] [Full text]
Pradeep AR, Bajaj P, Rao NS, Agarwal E, Naik SB. Platelet-rich fibrin combined with a porous hydroxyapatite graft for the treatment of 3-wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial. J Periodontol 2017;88:1288-96.
Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M. Treatment of periodontal intrabony defects with demineralized freeze-dried bone allograft in combination with platelet-rich plasma: A comparative clinical trial. J Periodontol 2008;79:802-10.
Mishra PR, Kolte AP, Kolte RA, Pajnigara NG, Shah KK. Comparative evaluation of open flap debridement alone and in combination with anorganic bone matrix/cell-binding peptide in the treatment of human infrabony defects: A randomized clinical trial. J Indian Soc Periodontol 2019;23:42-7.
] [Full text]
Juneja G, Bharti V. Treatment of periodontal intrabony defects with platelet-rich fibrin and hydroxyapatite. A comparative clinical and radiographic study using dentascan. Saint Int Dent J 2015;1:22-7. [Full text]
Yang XB, Bhatnagar RS, Li S, Oreffo RO. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 2004;10:1148-59.
Kumar PG, Kumar JA, Anumala N, Reddy KP, Avula H, Hussain SN. Volumetric analysis of intrabony defects in aggressive periodontitis patients following use of a novel composite alloplast: A pilot study. Quintessence Int 2011;42:375-84.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3], [Table 4]